ILF3 and osteosarcoma: The majority of dysregulated ncRNAs (hsa-miR-7-1-3p, hsa-miR-769-3p, hsa-miR-98-5p, hsa-miR-10a-3p, hsa-miR-365a-3p, ILF3-AS1, LINC01526 and LINC0139) are known to be involved in cell proliferation, metastasis and drug resistance in various other types of cancers and have not yet been explored in osteosarcoma [34, 38, 48–53].